Navigation Links
Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research
Date:12/27/2010

BOSTON--Dana Farber/Harvard Cancer Center (DF/HCC) will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation (PCF).

Judge Richard G. Stearns of the United States District Court for the District of Massachusetts awarded DF/HCC approximately $11.7 million in a cy pres ("near as possible") distribution of unclaimed funds from the settlement of a nationwide class action involving the marketing of the cancer drug Lupron(R). Judge Stearns made the award to DF/HCC after reviewing a number of proposals solicited from class members and the public.

The DF/HCC grant program will emphasize large-scale research collaborations on a national level and smaller-scale innovative pilot projects as well as research conducted by promising young investigators and talented graduate students. The goal is to catalyze innovative and collaborative research that will translate to meaningful clinical advances for prostate cancer patients and others.

"It is our vision that this program will further our scientific and clinical understanding of prostate cancer, lead to better and new treatments, and provide critical funds to young investigators to help them develop into the next generation of prostate cancer researchers," said Philip Kantoff, M.D, director of DF/HCC prostate cancer program.

Under the direction of Kantoff, who also leads the prostate cancer program at Dana-Farber Cancer Institute, the A. David Mazzone Awards Program will primarily fund research in the causes of prostate cancer as well as research in other diseases, like precocious puberty, for which Lupron has proven an effective treatment. The program leverages existing DF/HCC infrastructure and funding mechanisms, as well as a longstanding, collaborative relationship with PCF. DF/HCC and PCF will each administer research funds through their respective competitive grant programs. A call for applications is expected to occur in early 2011.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Related medicine news :

1. Gene Mutation Found in One of Four Cases of Deadly Brain Cancers
2. Penn researchers identify potential target for breast cancer therapy
3. Cancer Cells May Be Able to Urge Their Own Death
4. Recurrence of Oral Cancer Found to Signal Poor Outcome
5. Age plays too big a role in prostate cancer treatment decisions
6. UH biochemist works to revolutionize ovarian cancer treatment
7. Smoking may worsen pain for cancer patients
8. Tumor cells in blood may signal worse prognosis in head and neck cancer patients
9. Factors linked to speech/swallowing problems after treatment for head and neck cancers
10. Blacks with liver cancer more likely to die, study finds
11. Robotic surgery for head and neck cancer shows promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs available ... must find the one that works for them. When an inventor from Suisun City, ... worked and decided to share it with others. , He developed a prototype for ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... LYME, Conn. , Dec. 1, 2016  Today, ... has announced the honor of being selected as winners ... include: Simpson Healthcare Executives Website at the PLATINUM level, ... Conversations Training Module at the GOLD Level, and our ... At Simpson Healthcare Executives, we are excited ...
(Date:12/2/2016)... YORK , December 2, 2016 ... of its past losses following Trump,s victory early in ... potential, and fund managers are now predicting an uptick ... at four equities to see how they have fared ... CLDX ), Amicus Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology: